Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1619 of 6351
-
New pill aims to fight excessive daytime sleepiness
Symptom relief Recruiting nowThe purpose of this study is to measure the safety and decrease in daytime sleepiness in subjects with Idiopathic Hypersomnia when taking ALKS 2680 tablets compared with placebo tablets
Phase 2 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Friendly bacteria gel could tame eczema flares
Disease control Recruiting nowThis is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S. hominis A9 (ShA9) topical application as a treatment for atopic dermatitis (AD). The trial will enroll adults and pediatric parti…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Phlegm test could finally silence chronic cough in lung patients
Symptom relief Recruiting nowIn Interstitial Lung Disease (ILD) there is thickening of lung tissue, which makes it difficult for patients to breathe and get enough oxygen into their bodies. In addition to shortness of breath, daily cough is very common, with 4 out of 5 patients experiencing this symptom. Cou…
Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis study was a phase I safety and tolerability clinical trial conducted in a single-center, open-label, 3+3 design with dose escalation.
Phase 1 • Sponsor: Guangzhou FineImmune Biotechnology Co., LTD. • Aim: Disease control
Last updated Jun 26, 2026 13:03 UTC
-
New drug teclistamab tested for safety in Tough-to-Treat blood cancer
Disease control OngoingThe purpose of this study is to assess the safety of teclistamab in routine clinical practice when given as monotherapy in Indian participants with relapsed and refractory multiple myeloma (RRMM) (that is, a blood cancer that comes back after treatment or does not respond to trea…
Phase 4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New pill could tame stubborn hives
Disease control Recruiting nowThe purpose of this study is to explore the effect and Mechanism of Action (MoA) of remibrutinib (LOU064) vs. placebo on clinical outcomes in participants with Chronic Urticaria (CU), including both Chronic Spontaneous Urticaria (CSU) and Chronic Inducible Urticaria (CINDU).
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
New drug cocktail HRS-6209 shows promise in early breast cancer trial
Disease control Recruiting nowThis is a study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HRS-6209 combined with other treatment regimens in breast cancer patients, and preliminarily observe its anti-tumor efficacy.
Phase 1/2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common hand condition reveal hidden heart disease? new imaging trial investigates
Diagnosis By invitation onlyThis clinical trial will use the amyloid-binding radiotracer, 124I-evuzamitide, to potentially detect amyloid, in the heart and elsewhere, in patients who have a history of lumbar spinal stenosis and/or carpal tunnel syndrome.
Phase 2 • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
A handheld device that vibrates the airways may help COPD patients breathe easier
Symptom relief CompletedThe goal of this non-pharmacologic interventional study is to learn if Oscillatory Positive Expiratory Pressure (OPEP) therapy can improve disease impact and respiratory system dynamics in patients with COPD. The main questions it aims to answer are: Is OPEP therapy able to impr…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Could a tailored supplement boost nutrition while preserving Parkinson's drug power?
Symptom relief CompletedThe goal of this clinical trial is to learn if an amino acid supplement that is specifically made for people with Parkinson disease can improve nutrition without interfering with dopamine medication in people living with Parkinson disease. The main question it aims to answer is: …
Early phase 1 • Sponsor: UConn Health • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
A tiny file trick might make root canals less painful
Symptom relief CompletedThis prospective clinical study evaluated whether maintaining apical patency during single-visit root canal treatment influences postoperative pain in adults with single-rooted maxillary anterior teeth and chronic apical periodontitis. Participants were systematically allocated i…
Sponsor: Recep Tayyip Erdogan University • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Can adding dextrose or saline boost pain injection relief?
Symptom relief OngoingThis study aims to compare the effects of different ultrasound-guided periradicular injection solutions in patients with chronic unilateral radicular pain caused by a single-level lumbar disc herniation. Participants receive an ultrasound-guided periradicular injection containin…
Sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New combo therapy aims to boost esophageal cancer survival
Disease control Recruiting nowRationale: Esophageal cancer (EC) is the seventh most frequently diagnosed cancer and the sixth leading cause of cancer-related death worldwide. As a result of the late onset of symptoms, most patients with EC present in an advanced stage with a corresponding poor prognosis. Poor…
Phase 1 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Fat cells to the rescue? new treatment for arthritic knees enters human testing
Disease control Recruiting nowThis study is being conducted to evaluate the safety and tolerability of OA-SYS in patients with moderate to severe OA of the knee joint.
Phase 2 • Sponsor: Ageless Biotech, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:55 UTC
-
Mini stent offers hope for babies with blocked heart arteries
Disease control Recruiting nowThis Post-Approval Study is a single arm, prospective, multi-center, open-label study of patients treated with the Renata Minima Stent System in the United States. The objective of the study is to continue the assessment of device performance and capture outcome data on use of th…
Sponsor: Renata Medical • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New asthma drug verekitug tested for Long-Term safety
Disease control OngoingThe primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT study (NCT06196879).
Phase 2 • Sponsor: Upstream Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New trial aims to standardize heart valve repair for common birth defect
Disease control Recruiting nowBackground: Between one-third and one-half of patients with bicuspid aortic valve (BAV) disease develop significant aortic regurgitation (AR) at a young age, leading to cardiomyopathy and heart failure. Aortic valve repair is an evolving and still underused strategy in BAV patien…
Sponsor: University Hospital Augsburg • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Engineered immune cells take on recurrent brain tumors in early trial
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of anti-glycoprotein-A repetitions predominant (GARP) chimeric antigen receptor (CAR) T cell therapy and how well it works in treating patients with grade III or IV gliomas that have come back after a period of impr…
Phase 1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Simple blood test could predict stomach cancer risk
Knowledge-focused Recruiting nowInvestigator propose the implementation of circulating biomarker monitoring, focusing on molecules related to the progression of gastric atrophy and/or associated with gastric cancer. Monitoring these biomarkers will provide gastroenterologists with timely information on individ…
Sponsor: Centro di Riferimento Oncologico - Aviano • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
A personalized clinic may help advanced cancer patients feel better
Symptom relief Recruiting nowTo conduct a feasibility trial to examine the feasibility and acceptability of conducting a randomized controlled trial that evaluates the effect of the survivorship care intervention on patient-reported outcomes, defined as symptom distress and health-related quality of life.
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC